Covid-19 vaccine maker Novavax raised doubts Tuesday about its ability to continue its business, announcing plans to cut spending after struggles in rolling out its coronavirus jab.

Vaccine maker Novavax says ‘substantial doubt’ on ability to stay in business

The Serum Institute of India is preparing to produce 1.1 billion doses of Novavax's COVID-19 vaccine in the country, NITI Aayog member Vinod Kumar Paul said at a press briefing on Tuesday.

Novavax vaccine efficacy data promising, clinical trials in India in advanced stage, says VK Paul

Novavax Inc on Monday reported late-stage data from its US-based clinical trial showing its vaccine is more than 90 per cent effective against COVID-19 across a variety of variants of the virus.

US biotech firm Novavax says COVID-19 jab is over 90% effective

As the Biden administration announced it will share 80 million vaccine doses with the world community, the White House said it will lift the Defense Production Act ratings on the AstraZeneca, Novavax and Sanofi COVID-19 vaccines.

US to lift Defense Production Act ratings on AstraZeneca, Novavax and Sanofi vaccines: White House

US biotech firm Novavax said on Monday it had started clinical trials of its proposed Covid vaccine on children, in a programme that will involve up to 3,000 adolescents aged 12-17.

Novavax starts Covid vaccine trials on children

The UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees in north-east England.

UK has secured 60 Mn doses of highly effective Novavax vaccine, PM Boris Johnson thanks trial volunteers

novavax-vaccine

Novavax Vaccine, News on Novavax Vaccine, stories on Novavax Vaccine, articles on Novavax Vaccine, Novavax Vaccine stories at Wion, Novavax Vaccine news, Novavax Vaccine latest news